Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304485 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift PLOS ONE, 2024. Verfasst von Keming Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department of General Hospital, Ningxia Medical University, Ningxia, China. Hauptthemen laut MEDLINE: Erectile Dysfunction, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, National Natural Science Foundation of China, Ningxia Key Research and Development Project.
Abstract (Originalsprache)
Objective
This study aims to explore the impact of Nesfatin-1 on type 2 diabetic erectile dysfunction (T2DMED) and its underlying mechanism in regulating the phenotypic switching of corpus cavernosum smooth muscle cells (CCSMCs).
Methods
Twenty-four 4-week-old male C57 wild-type mice were randomly assigned to the control group, model group, and Nesfatin-1 treatment group. Monitoring included body weight, blood glucose levels, and penile cavernous pressure (ICP). Histochemistry and Western blot analyses were conducted to assess the expressions of α-SMA, OPN, and factors related to the PI3K/AKT/mTOR signaling pathway. CCSMCs were categorized into the control group, high glucose and high oleic acid group (GO group), Nesfatin-1 treatment group (GO+N group), sildenafil positive control group (GO+S group), and PI3K inhibitor group (GO+N+E group). Changes in phenotypic markers, cell morphology, and the PI3K/AKT/mTOR signaling pathway were observed in each group.
Results
(1) Nesfatin-1 significantly ameliorated the body size, body weight, blood glucose, glucose tolerance, and insulin resistance in T2DMED mice. (2) Following Nesfatin-1 treatment, the ICP/MSBP ratio and the peak of the ICP curve demonstrated a significant increase. (3) Nesfatin-1 significantly enhanced smooth muscle and reduced collagen fibers in the corpus cavernosum. (4) Nesfatin-1 notably increased α-SMA expression and decreased OPN expression in CCSMCs. (5) Nesfatin-1 elevated PI3K, p-AKT/AKT, and p-mTOR/mTOR levels in penile cavernous tissue.
Conclusions
Nesfatin-1 not only effectively improves body weight and blood glucose levels in diabetic mice but also enhances erectile function and regulates the phenotypic switching of corpus cavernosum smooth muscle. The potential mechanism involves Nesfatin-1 activating the PI3K/AKT/mTOR signaling pathway to induce the conversion of CCSMCs to a contractile phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Urology Department of General Hospital, Ningxia Medical University, Ningxia, China.
- Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, China.
ORCID-Profile: Guangyong Li
Förderung
- NIBIB NIH HHS
- National Natural Science Foundation of China
- Ningxia Key Research and Development Project
- Ningxia Natural Science Foundation
- Ningxia science and technology innovation leading talent training project
- ,Ningxia Medical University research project
Zitieren
APA
Chen, K., Huang, B., Feng, J., Hu, Z., Fan, S., Ren, S., Tian, H., Abdulkarem M M, A. M., Wang, X., Tuo, Y., Liang, X., Xie, H., He, R., & Li, G. (2024). Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction. PLOS ONE. https://doi.org/10.1371/journal.pone.0304485
Vancouver
Chen K, Huang B, Feng J, Hu Z, Fan S, Ren S, et al. Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction. PLOS ONE. 2024. doi:10.1371/journal.pone.0304485
BibTeX
@article{Chen2024,
author = {Chen, Keming and Huang, Bincheng and Feng, Jiajing and Hu, Zhengxing and Fan, Shuzhe and Ren, Shuai and Tian, Haifu and Abdulkarem M M, Al-Qaisi Mohammed and Wang, Xuehao and Tuo, Yunshang and Liang, Xiaoxia and Xie, Haibo and He, Rui and Li, Guangyong},
title = {Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304485}
}
EUVIMED